4.4 Article

Phage-Derived Oncolytic Viruses with 3C from Seneca Valley Virus for Targeted Therapy of Cervical Cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biotechnology & Applied Microbiology

Infectious recombinant Senecavirus A expressing novel reporter proteins

Minmin Wang et al.

Summary: The construction of SVA viruses expressing reporter genes like green fluorescent protein (iLOV), red fluorescent protein (RFP), or NanoLuc luciferase (Nluc) provides a powerful tool for virus research. The genetic stability analysis revealed that V-GD05-iLOV was highly stable in retaining the iLOV gene, while V-GD05-RFP and V-GD05-Nluc lost the foreign genes in passages. The study also identified anthrax toxin receptor 1 (ANTXR1) as the receptor for SVA to invade porcine cells, which can help in understanding virus pathogenesis and developing control measures.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2021)

Review Infectious Diseases

Genetic and Chemical Engineering of Phages for Controlling Multidrug-Resistant Bacteria

Dingming Guo et al.

Summary: This article discusses the emergence and spread of multidrug-resistant bacteria due to excessive antibiotic use, and the potential of phage therapy as an alternative strategy. The methods of genetically and chemically engineering phages to enhance their bactericidal efficiency in controlling multidrug-resistant pathogens are highlighted. The obstacles faced by this new antimicrobial approach are also presented.

ANTIBIOTICS-BASEL (2021)

Review Chemistry, Medicinal

Bacteriophages as Therapeutic and Diagnostic Vehicles in Cancer

Valentina Foglizzo et al.

Summary: The evolution of nanomedicine involves redesigning carriers to create new therapeutic and diagnostic platforms. Bacteriophage research has shown potential in drug and gene delivery, with the ability to display specific molecular determinants on their surface. Phages can be used as carriers for imaging molecules and therapeutics, and their genetic material can be manipulated for gene therapy purposes. They hold promise as anticancer agents with the potential for systemic administration and modulation of their immunogenic profile for vaccine production in immuno-oncology.

PHARMACEUTICALS (2021)

Article Microbiology

Characteristics of a Bacteriophage, vB_Kox_ZX8, Isolated From Clinical Klebsiella oxytoca and Its Therapeutic Effect on Mice Bacteremia

Ping Li et al.

Summary: A novel bacteriophage vB_Kox_ZX8 specifically infecting K. oxytoca AD3 was isolated from human fecal samples. In vitro studies showed high lysis efficiency, a stable pH range, and a short incubation period. In vivo experiments demonstrated that vB_Kox_ZX8 effectively treated bacteremia induced by K. oxytoca in BALB/c mice with no observed side effects.

FRONTIERS IN MICROBIOLOGY (2021)

Article Biochemistry & Molecular Biology

Bacteriophage-mediated therapy of chondrosarcoma by selective delivery of the tumor necrosis factor alpha (TNFα) gene

Aitthiphon Chongchai et al.

Summary: A targeted chondrosarcoma gene therapy using engineered phage particles showed promising, selective, and efficient delivery of therapeutic genes to chondrosarcoma cells. In vitro studies demonstrated significant cell killing and high expression of TNF alpha and apoptosis-related genes when treated with the targeted particles. In vivo experiments on mice with chondrosarcoma further supported the potential of this phage-based therapy for chondrosarcoma.

FASEB JOURNAL (2021)

Review Chemistry, Medicinal

Bacteriophages as Potential Tools for Use in Antimicrobial Therapy and Vaccine Development

Beata Zalewska-Piatek et al.

Summary: Traditional vaccines based on bacteria or viruses are generally effective in preventing and controlling various infectious diseases in humans, but they have issues with stability, transport, targeted delivery, safe use, and side effects. Experimental phage therapy based on viruses replicating in bacterial cells offers great potential in the treatment of bacterial infections resistant to commonly used antibiotics.

PHARMACEUTICALS (2021)

Review Chemistry, Multidisciplinary

Recent Advances in Engineered Materials for Immunotherapy-Involved Combination Cancer Therapy

Jun-Long Liang et al.

Summary: Immunotherapy combined with other therapeutic modalities is an effective strategy to enhance cancer treatment outcomes. Recent research has focused on the combination of immunotherapy with chemotherapy, phototherapy, radiotherapy, etc., while also discussing critical challenges and future research directions.

ADVANCED MATERIALS (2021)

Review Obstetrics & Gynecology

Protective operative techniques in radical hysterectomy in early cervical carcinoma and their influence on disease-free and overall survival: a systematic review and meta-analysis of risk groups

Johanna Kampers et al.

Summary: This meta-analysis comparing robotic and laparoscopic hysterectomy to open hysterectomy for early cervical cancer found that laparoscopic surgery generally had lower overall survival rates compared to open surgery. However, the use of protective operating techniques, such as avoiding uterine manipulators and using vaginal colpotomy, was associated with improved disease-free survival in laparoscopy.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2021)

Review Virology

Oncolytic Virotherapy Treatment of Breast Cancer: Barriers and Recent Advances

Amy Kwan et al.

Summary: Oncolytic virotherapy is a promising immunotherapeutic approach for breast cancer, with the potential to overcome the immunogenic cold nature of the tumor. While pre-clinical studies have shown promise, the challenges of monotherapy limitations and specific barriers in the breast cancer population need to be addressed for successful clinical trials.

VIRUSES-BASEL (2021)

Review Virology

Oncolytic HSV: Underpinnings of Tumor Susceptibility

Chase Kangas et al.

Summary: Oncolytic herpes simplex virus (oHSV) has shown success in cancer treatment, but there is room for improvement. Current understanding of the molecular basis for tumor susceptibility to oHSV is still evolving, focusing on malignant suppression of nucleic acid sensing and strategies to enhance clinical efficacy of these therapeutic viruses.

VIRUSES-BASEL (2021)

Review Virology

Combinatorial Approaches for Cancer Treatment Using Oncolytic Viruses: Projecting the Perspectives through Clinical Trials Outcomes

Alexander Malogolovkin et al.

Summary: Recent breakthroughs in cancer immunotherapy have transformed oncology and provided new hope for a cure. The combination of oncolytic viruses with immune checkpoint inhibitors shows promise, but finding the most effective combinations remains complex. This review highlights the efficacy, safety, and future perspectives of virotherapy based on clinical trial data.

VIRUSES-BASEL (2021)

Review Microbiology

Oncolytic Adenovirus: Prospects for Cancer Immunotherapy

Yaqi Zhao et al.

Summary: Immunotherapy, particularly utilizing oncolytic viruses like adenovirus, has become a forefront approach in modern oncologic treatment. Genetic engineering allows for the design of oncolytic adenoviruses with better tumor targeting and efficacy, and strategies like adding tumor-specific promoters and immunostimulatory transgenes have shown promise in cancer immunotherapy. Combining oncolytic adenoviruses with immune checkpoint inhibitors has demonstrated increased clinical benefit in ongoing trials, although challenges such as antiviral immune response and tumor microenvironment obstruction need to be addressed.

FRONTIERS IN MICROBIOLOGY (2021)

Review Health Care Sciences & Services

The role of trust in HPV vaccine uptake among racial and ethnic minorities in the United States: a narrative review

Nicole Harrington et al.

Summary: The review found that vaccination coverage of the HPV vaccine is suboptimal among racial and ethnic minority populations in the US. Lack of trust in doctors and healthcare institutions may contribute to lower vaccine uptake. Minority groups are more likely to trust family members, religious organizations, and media sources compared to their white counterparts.

AIMS PUBLIC HEALTH (2021)

Article Microbiology

Safety of bacteriophage therapy in severe Staphylococcus aureus infection

Aleksandra Petrovic Fabijan et al.

NATURE MICROBIOLOGY (2020)

Review Oncology

The Oncolytic Virus in Cancer Diagnosis and Treatment

Guo-dong Cao et al.

FRONTIERS IN ONCOLOGY (2020)

Review Biotechnology & Applied Microbiology

Phage display as a tool for vaccine and immunotherapy development

Krystina L. Hess et al.

BIOENGINEERING & TRANSLATIONAL MEDICINE (2020)

Article Biochemistry & Molecular Biology

Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus

Rebekah M. Dedrick et al.

NATURE MEDICINE (2019)

Article Virology

Recent advances in oncolytic virus-based cancer therapy

Luo-Qin Fu et al.

VIRUS RESEARCH (2019)

Article Pharmacology & Pharmacy

DNX-2401: an investigational drug for the treatment of recurrent glioblastoma

Brandon Philbrick et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)

Review Pharmacology & Pharmacy

Phage-based vaccines

Qing Bao et al.

ADVANCED DRUG DELIVERY REVIEWS (2019)

Article Pharmacology & Pharmacy

Engineering Biomaterials to Direct Innate Immunity

Robert S. Oakes et al.

ADVANCED THERAPEUTICS (2019)

Article Immunology

Senecavirus A 3C Protease Mediates Host Cell Apoptosis Late in Infection

Maureen H. Fernandes et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Oncology

Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors

Jonathan G. Pol et al.

ONCOIMMUNOLOGY (2018)

Article Multidisciplinary Sciences

Structural basis for anthrax toxin receptor 1 recognition by Seneca Valley Virus

Nadishka Jayawardena et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Review Immunology

Cervical cancer screening in rural India: Status & current concepts

Anand Narain Srivastava et al.

INDIAN JOURNAL OF MEDICAL RESEARCH (2018)

Review Immunology

Integrating oncolytic viruses in combination cancer immunotherapy

Praveen K. Bommareddy et al.

NATURE REVIEWS IMMUNOLOGY (2018)

Article Medicine, Research & Experimental

Anthrax toxin receptor 1 is the cellular receptor for Seneca Valley virus

Linde A. Miles et al.

JOURNAL OF CLINICAL INVESTIGATION (2017)

Article Multidisciplinary Sciences

Selective replication of oncolytic virus M1 results in a bystander killing effect that is potentiated by Smac mimetics

Jing Cai et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Biotechnology & Applied Microbiology

Host- and pathogen-derived adjuvant coatings on protein nanoparticle vaccines

Timothy Z. Chang et al.

BIOENGINEERING & TRANSLATIONAL MEDICINE (2017)

Review Pharmacology & Pharmacy

Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos

Mahdi Karimi et al.

ADVANCED DRUG DELIVERY REVIEWS (2016)

Review Oncology

Oncolytic virus therapy: A new era of cancer treatment at dawn

Hiroshi Fukuhara et al.

CANCER SCIENCE (2016)

Article Multidisciplinary Sciences

AAVP displaying octreotide for ligand-directed therapeutic transgene delivery in neuroendocrine tumors of the pancreas

Tracey L. Smith et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Review Cell Biology

Phage display as a promising approach for vaccine development

Leili Aghebati-Maleki et al.

JOURNAL OF BIOMEDICAL SCIENCE (2016)

Review Microbiology

Safety and efficacy of phage therapy via the intravenous route

Peter Speck et al.

FEMS MICROBIOLOGY LETTERS (2016)

Article Chemistry, Organic

M13 Bacteriophage-Based Self-Assembly Structures and Their Functional Capabilities

Jong-Sik Moon et al.

MINI-REVIEWS IN ORGANIC CHEMISTRY (2015)

Article Oncology

Selective Tropism of Seneca Valley Virus for Variant Subtype Small Cell Lung Cancer

J. T. Poirier et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)

Review Biotechnology & Applied Microbiology

Oncolytic virotherapy

Stephen J. Russell et al.

NATURE BIOTECHNOLOGY (2012)

Article Biotechnology & Applied Microbiology

Beyond natural antibodies: the power of in vitro display technologies

Andrew R. M. Bradbury et al.

NATURE BIOTECHNOLOGY (2011)

Article Biotechnology & Applied Microbiology

Complete genome sequence analysis of Seneca Valley virus-001, a novel oncolytic picornavirus

Laura M. Hales et al.

JOURNAL OF GENERAL VIROLOGY (2008)

Article Oncology

Seneca valley virus, a systemically deliverable oncolytic picornavirus, and the treatment of neuroendocrine cancers

P. Seshidhar Reddy et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)

Article Biochemical Research Methods

Design and construction of targeted AAVP vectors for mammalian cell transduction

Amin Hajitou et al.

NATURE PROTOCOLS (2007)

Article Biochemistry & Molecular Biology

A hybrid vector for ligand-directed tumor targeting and molecular imaging

A Hajitou et al.